Erin K. Reagan

Erin K. Reagan

Auto-generated profile, based on publicly available information

Erin K. Reagan

Division of Infectious Diseases, University of Pennsylvania, 3400 Civic Center Blvd., Philadelphia, 19104, United States

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2021 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
DZDapeng Zhang
Dapeng Zhang
EAElena N. Atochina-Vasserman
Elena N. Atochina-Vasserman
DMDevendra Surendrakumar Maurya
Devendra Surendrakumar Maurya
MLMatthew Liu
Matthew Liu
QXQi Xiao
Qi Xiao
VPVirgil Percec
Virgil Percec

9 March 2022 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
DZDapeng Zhang
Dapeng Zhang
EAElena N. Atochina-Vasserman
Elena N. Atochina-Vasserman
JLJuncheng Lu
Juncheng Lu
DMDevendra Surendrakumar Maurya
Devendra Surendrakumar Maurya
QXQi Xiao
Qi Xiao
VPVirgil Percec
Virgil Percec

22 August 2023 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JLJuncheng Lu
Juncheng Lu
EAElena N. Atochina-Vasserman
Elena N. Atochina-Vasserman
DMDevendra Surendrakumar Maurya
Devendra Surendrakumar Maurya
Dipankar SahooDipankar Sahoo
Dipankar Sahoo
NONathan Ona
Nathan Ona
VPVirgil Percec
Virgil Percec

21 February 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
JMJaclynn A. Meshanni
Jaclynn A. Meshanni
ESEmily R. Stevenson
Emily R. Stevenson
DZDapeng Zhang
Dapeng Zhang
RSRachel Sun
Rachel Sun
NONathan A. Ona
Nathan A. Ona
EAElena N. Atochina-Vasserman
Elena N. Atochina-Vasserman
Current clinical strategies for the delivery of pulmonary therapeutics to the lung are primarily targeted to the upper portions of the airways, such as treatment with nebulized instillation and inhalation. However, targeted delivery to the lower regions of the lung is necessary for the treatment of parenchymal lung injury and disease. Here, we show the development of an mRNA therapeutic for the lower lung in mice using one-component Ionizable Amphiphilic Janus Dendrimers as a delivery vehicle. We deliver an anti-inflammatory cytokine mRNA, transforming growth factor-beta, to produce transient protein expression in the lower regions of the lung. This study highlights a method for precise, effective, and safe delivery of TGF-β mRNA to the lung in mice. This delivery system offers a promising approach for targeting therapeutics to the specific tissues, a strategy necessary to fill the current clinical gap in treating parenchymal lung injury and disease.

18 March 2023 in npj Vaccines
Verified
Journal Article
Open access
PDF file
TPTapas Patra
Tapas Patra
KMKeith Meyer
Keith Meyer
YHYuki Haga
Yuki Haga
ERErin K. Reagan
Erin K. Reagan
DWDrew Weissman
Drew Weissman
Ratna B. RayRatna B. Ray
Ratna B. Ray
Hepatitis C virus (HCV) is characterized by a high number of chronic cases due to an impairment of protective innate and adaptive immune responses. Here, we examined the contribution of the individual ectodomains of E1, E2, or a modified E2 with reduced CD81 binding and an inserted N-linked glycosylation site in combination as vaccine antigen mRNA-lipid nanoparticles (LNPs). The induction of a protective immune response to surrogate recombinant vaccinia virus (VV) expressing homologous HCV glycoprotein(s) challenge infection in a BALB/c mouse model was observed. Vaccination with a mRNA-LNP expressing soluble E1 (sE1) significantly reduced vv/HCV titer in the mouse ovary. However, the addition of sE2 mRNA-LNP for immunization impaired the efficacy of the sE1 construct. Further analysis showed that Th1 related cytokine responses to the sE1 mRNA-LNP were significantly altered in the presence of sE2 following co-immunization. Evaluation of immunogenicity revealed that the use of modified sE2F442NYT nucleoside mRNA-LNP vaccine results in an improved cellular immune response, IgG2a isotype switching, enhanced total IgG, and an increase in the neutralizing antibody response against HCV pseudotype virus. HCV cross genotype specific reactivity to peptides representing conserved E2 specific linear epitopes were enhanced in modified E2 vaccinated animal sera. In the absence of a suitable immunocompetent small animal model for HCV infection, protection from surrogate HCV vaccinia challenge infection model was observed in the immunized mice as compared to sE1 alone or an unmodified sE2 mRNA-LNP vaccine. Inclusion of sE1 with modified sE2F442NYT as mRNA-LNP vaccine candidate appeared to be beneficial for protection.

31 May 2021 in Education Sciences
Verified
Journal Article
Open access
PDF file
SLsoro l.o.
soro l.o.
EPElana Pyfrom
Elana Pyfrom
JHJacob A. Hoffman
Jacob A. Hoffman
CPChristopher Pai
Christopher Pai
ERErin K. Reagan
Erin K. Reagan
ALAlysson E. Light
Alysson E. Light
This study reviews literature on racially equitable admissions practices relevant to graduate programs in STEM. Graduate Record Exam (GRE) scores correlate more strongly with race, gender, and socioeconomic status than performance metrics for research during or after graduate school. Structural changes to admissions processes that can improve equity of admissions decisions and reduce correlations between admissions decisions and demographic data include using holistic review or composite scores that quantize more components of an application, removing hard limits on course requirements, admitting students as a cohort instead of to individual faculty sponsors, and diversifying admissions committees. Some alternative scoring methods attempt to measure personality traits, but performing these measurements during admissions may present difficulties. Bridge programs—whether they are implemented as collaborations with a minority-serving institution, a personalized educational program for each student admitted to a program, or a stand-alone program before the doctoral degree program—may be able to improve both recruitment and retention of students with underrepresented racial and ethnic identities in their field of study. Finally, financial barriers to applications can disproportionately affect underrepresented applicants due to systemic racism. We end with recommendations for graduate programs to improve equity in admissions processes.